IOBT Past Earnings Q&A
What was the best and worst IOBT past earnings results?
For IO Biotech, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
The highest IOBT past earnings result in our data set was -0.600/share posted in Q1 2022, while the lowest was in Q1 2022 when IOBT posted -0.600/share.
The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when IOBT reported NA in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at NA of revenue.
There are 1 IOBT past earnings results in our data set.
On this page we presented the IOBT past earnings date information for IO Biotech. Reviewing that
IOBT Past Earnings
for the company, we see that the highest past earnings result in our data set was in Q1 2022, when IOBT posted gaap of -0.600/share. Meanwhile the lowest IOBT past earnings result was in Q1 2022, when IOBT posted gaap of -0.600/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when IOBT reported NA in revenue, while the smallest revenue quarter was Q1 2022 when IOBT reported NA in revenue.
Any self directed investor doing their due diligence on IOBT or any other given stock can benefit from
researching all of the IO Biotech past earnings — and here, we present each quarter's result all together
on one page for easy comparison. Studying this information can help when projecting future earnings, as well
as determining whether the past earnings trajectory justifies the current stock value.
That's why we bring you PastEarnings
.com to make it easy for investors to investigate
IO Biotech past earnings, or the past earnings information for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for earnings
surprises history (beat/miss data) as well as next earnings dates for IOBT. Thanks for visiting, and the next
time you need to research IOBT past earnings
or those of another stock, we hope you'll think of our site, as your
go-to past earnings research resource of choice.